STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.
- S. Katz, A. B. Ford, R. Moskowitz, B. A. Jackson, M. W. Jaffe
- MedicineJAMA
- 21 September 1963
The observation that theOrder of recovery of Index functions in disabled patients is remarkably similar to the order of development of primary functions in children suggests that the Index is based on primary biological and psychosocial function, reflecting the adequacy of organized neurological and locomotor response.
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.
- W. Zhang, R. Moskowitz, P. Tugwell
- MedicineOsteoarthritis and Cartilage
- 1 February 2008
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
- D. Clegg, D. Reda, H. J. Williams
- MedicineNew England Journal of Medicine
- 1 February 2006
Exploratory analyses suggest that the combination of glucosamine and chondroitin sulfate may be effective in the subgroup of patients with moderate-to-severe knee pain, and the efficacy and safety of these treatments as a treatment for knee pain from osteoarthritis are evaluated.
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.
- W. Zhang, G. Nuki, P. Tugwell
- MedicineOsteoarthritis and Cartilage
- 1 April 2010
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.
- W. Zhang, R. Moskowitz, P. Tugwell
- MedicineOsteoarthritis and Cartilage
- 1 September 2007
Guidelines for the medical management of osteoarthritis
- M. Hochberg, R. Altman, T. Schnitzer
- Medicine
- 1 November 1995
Differences in approach and treatment strategies which are unique to OA of the knee, including the role of intraarticular corticosteroid injections, will be discussed.
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines.
- R. Altman, M. Hochberg, R. Moskowitz, T. Schnitzer
- MedicineArthritis & Rheumatism
- 2000
Role of collagen hydrolysate in bone and joint disease.
- R. Moskowitz
- MedicineSeminars in Arthritis & Rheumatism
- 1 October 2000
Collagen hydrolysate is of interest as a therapeutic agent of potential utility in the treatment of osteoarthritis and osteoporosis, and its high level of safety makes it attractive as an agent for long-term use in these chronic disorders.
Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology.
- M. Hochberg, R. Altman, T. Schnitzer
- MedicineArthritis & Rheumatism
- 1 November 1995
The role of joint lavage and arthroscopic debridement in patients with OA of the knee who are unresponsive to conservative medical therapy needs further study, and these procedures cannot be routinely recommended for all patients at this time.
Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
- R. Altman, R. Moskowitz
- MedicineJournal of Rheumatology
- 1 November 1998
This large, controlled randomized clinical trial confirms that 5 weekly IA injections of HA (Hyalgan) in patients with OA of the knee are generally well tolerated, provide sustained relief of pain and improved patient function, and were at least as effective with fewer adverse reactions as continuous treatment with naproxen for 26 weeks.
...
...